News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
406,939 Results
Type
Article (27659)
Company Profile (63)
Press Release (379215)
Multimedia
Podcasts (36)
Webinars (7)
Section
Business (108178)
Career Advice (625)
Deals (17485)
Drug Delivery (55)
Drug Development (49312)
Employer Resources (57)
FDA (12646)
Job Trends (8773)
News (192752)
Policy (20127)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (1840)
Accelerated approval (16)
Adcomms (10)
Allergies (110)
Alliances (28021)
ALS (99)
Alzheimer's disease (1000)
Antibody-drug conjugate (ADC) (165)
Approvals (12971)
Artificial intelligence (312)
Autoimmune disease (89)
Automation (10)
Bankruptcy (146)
Best Places to Work (7115)
BIOSECURE Act (5)
Biosimilars (78)
Biotechnology (42)
Bladder cancer (124)
Brain cancer (40)
Breast cancer (420)
Cancer (3105)
Cardiovascular disease (275)
Career advice (555)
Career pathing (17)
CAR-T (136)
CDC (27)
Celiac Disease (2)
Cell therapy (376)
Cervical cancer (26)
Clinical research (44140)
Collaboration (865)
Compensation (271)
Complete response letters (17)
COVID-19 (1656)
CRISPR (36)
C-suite (490)
Cystic fibrosis (61)
Data (4293)
Decentralized trials (2)
Denatured (20)
Depression (94)
Diabetes (325)
Diagnostics (3859)
Digital health (28)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (97)
Drug pricing (95)
Drug shortages (24)
Duchenne muscular dystrophy (125)
Earnings (39566)
Editorial (31)
Employer branding (8)
Employer resources (53)
Events (55269)
Executive appointments (596)
FDA (14955)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (11)
Funding (776)
Gene editing (78)
Generative AI (21)
Gene therapy (269)
GLP-1 (559)
Government (3240)
Grass and pollen (4)
Guidances (234)
Healthcare (12563)
HIV (38)
Huntington's disease (20)
IgA nephropathy (51)
Immunology and inflammation (92)
Immuno-oncology (25)
Indications (69)
Infectious disease (1797)
Inflammatory bowel disease (110)
Inflation Reduction Act (8)
Influenza (56)
Intellectual property (121)
Interviews (82)
IPO (7257)
IRA (25)
Job creations (1911)
Job search strategy (496)
JPM (21)
Kidney cancer (10)
Labor market (37)
Layoffs (210)
Leadership (12)
Legal (3782)
Liver cancer (67)
Longevity (8)
Lung cancer (486)
Lymphoma (251)
Machine learning (16)
Management (22)
Manufacturing (305)
MASH (108)
Medical device (13398)
Medtech (13444)
Mergers & acquisitions (10753)
Metabolic disorders (768)
Multiple sclerosis (98)
NASH (11)
Neurodegenerative disease (169)
Neuropsychiatric disorders (43)
Neuroscience (1738)
NextGen: Class of 2026 (4111)
Non-profit (2966)
Now hiring (33)
Obesity (316)
Opinion (110)
Ovarian cancer (121)
Pain (150)
Pancreatic cancer (144)
Parkinson's disease (169)
Partnered (19)
Patents (229)
Patient recruitment (353)
Peanut (42)
People (36995)
Pharmaceutical (15)
Pharmacy benefit managers (16)
Phase 1 (12701)
Phase 2 (19128)
Phase 3 (15647)
Pipeline (3099)
Policy (138)
Postmarket research (1712)
Preclinical (4000)
Press Release (22)
Prostate cancer (180)
Psychedelics (26)
Radiopharmaceuticals (179)
Rare diseases (449)
Real estate (2978)
Recruiting (22)
Regulatory (16124)
Reports (19)
Research institute (1711)
Resumes & cover letters (77)
Rett syndrome (16)
RNA editing (6)
RSV (43)
Schizophrenia (117)
Series A (121)
Series B (97)
Service/supplier (3)
Sickle cell disease (49)
Special edition (6)
Spinal muscular atrophy (109)
Sponsored (17)
Startups (2230)
Stomach cancer (11)
Supply chain (62)
Tariffs (30)
The Weekly (16)
Vaccines (529)
Venture capital (32)
Weight loss (214)
Women's health (56)
Worklife (4)
Date
Last 7 days (310)
Last 30 days (1128)
Last 365 days (16491)
2026 (1506)
2025 (16839)
2024 (20304)
2023 (23354)
2022 (31474)
2021 (33983)
2020 (33326)
2019 (29531)
2018 (22627)
2017 (19675)
2016 (18852)
2015 (21991)
2014 (16604)
2013 (13710)
2012 (14883)
2011 (15125)
2010 (13612)
Location
Africa (410)
Alabama (31)
Alaska (4)
Arizona (176)
Arkansas (10)
Asia (26198)
Australia (4254)
California (5662)
Canada (1943)
China (787)
Colorado (288)
Connecticut (315)
Delaware (249)
Europe (51997)
Florida (972)
Georgia (227)
Hawaii (1)
Idaho (35)
Illinois (582)
India (32)
Indiana (383)
Iowa (13)
Japan (318)
Kansas (90)
Kentucky (19)
Louisiana (18)
Maine (29)
Maryland (898)
Massachusetts (3815)
Michigan (152)
Minnesota (442)
Mississippi (5)
Missouri (79)
Montana (19)
Nebraska (22)
Nevada (66)
New Hampshire (73)
New Jersey (1955)
New Mexico (10)
New York (1581)
North Carolina (879)
North Dakota (4)
Northern California (2687)
Ohio (219)
Oklahoma (10)
Oregon (28)
Pennsylvania (1363)
Puerto Rico (11)
Rhode Island (35)
South America (565)
South Carolina (59)
Southern California (2270)
Tennessee (127)
Texas (1043)
United States (22047)
Utah (197)
Virginia (146)
Washington D.C. (53)
Washington State (401)
West Virginia (4)
Wisconsin (71)
Wyoming (1)
406,939 Results for "extremity medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Humacyte Announces Hospital Charge Data Showing High Expense of Preventable Extremity Arterial Injury Complications
January 8, 2026
·
11 min read
Press Releases
Humacyte Announces Publication of Long-Term Safety and Efficacy Results of Symvess® in Extremity Trauma Repair
December 23, 2025
·
11 min read
Press Releases
RevBio® Receives First FDA Approval for a “Bone Glue” to Treat Extremity Fractures in a Clinical Trial
November 4, 2025
·
4 min read
Press Releases
Last Patient Completes Biofrontera’s Phase 1 Pharmacokinetics Study of Ameluz® for Treatment of Actinic Keratoses on the Trunk and Extremities
December 5, 2025
·
5 min read
Press Releases
Humacyte Announces Publication of New Data Comparing Symvess™ to Autologous Vein in Extremity Arterial Trauma
October 31, 2025
·
10 min read
Pharm Country
Extremity Medical to Expand Orthopedic Extremity Implant Systems Through Strategic Relationship With Henry Schein as Well as Growth Financings
In a landmark development for the orthopedic implant industry, Extremity Medical LLC, a pioneering medical engineering firm, has announced a strategic relationship with Henry Schein, Inc., a global healthcare solutions company.
January 11, 2024
·
2 min read
Press Releases
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
February 4, 2026
·
2 min read
Press Releases
Neuraptive Therapeutics, Inc. Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating the Safety and Efficacy of NTX-001 Compared to Standard of Care in the Treatment of Upper Extremity Transected Nerves Requiring Surgical Repair
October 3, 2025
·
2 min read
Press Releases
Kuros Biosciences Expands into Extremities Markets
November 19, 2024
·
5 min read
Pharm Country
Henry Schein Enters Extremity Segment of Orthopedic Market
Henry Schein, Inc. announced plans to enter the upper- and lower-extremities specialty segment of the orthopedic market in line with our long-standing strategy.
December 20, 2023
·
9 min read
1 of 40,694
Next
